Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporotic women

Mickael Hiligsmann*, Annelies Boonen, Carmen D. Dirksen, Wafa Ben Sedrine, Jean-Yves Reginster

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporotic women'. Together they form a unique fingerprint.

Keyphrases

INIS

Pharmacology, Toxicology and Pharmaceutical Science